Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Cost of Goods Sold

Arena Pharmaceuticals Cost of Goods Sold Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Cost of Goods Sold from 2000 to 2018.
  • Arena Pharmaceuticals Cost of Goods Sold for the quarter ending December 12, 2018 was $38m a 43.06% increase of 16m year over year
  • Arena Pharmaceuticals Cost of Goods Sold for the last 12 months ending December 12, 2018 was $115m a 32.87% increase of 38m year over year
  • Arena Pharmaceuticals Annual Cost of Goods Sold for 2018 was $115m a 38.29% increase of 44m from 2017
  • Arena Pharmaceuticals Annual Cost of Goods Sold for 2017 was $71m a 10.15% increase of 7m from 2016
  • Arena Pharmaceuticals Annual Cost of Goods Sold for 2016 was $64m a -30.57% decrease of -20m from 2015
Other Income Statement Metrics:
  • Arena Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-44m a 31.55% decrease of -14m year over year
  • Arena Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $69m a 146.52% increase of 101m year over year
  • Arena Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Cost of Goods Sold Data

12/2018$38m
09/2018$29m
06/2018$27m
03/2018$22m
12/2017$21m
09/2017$17m
06/2017$18m
03/2017$15m
09/2016$20m
06/2016$21m

Annual ARNA Cost of Goods Sold Data

2018$115m
2017$71m
2016$64m
2015$83m
2014$108m
2013$73m
2012$58m
2011$67m
2010$83m
2009$117m